These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. New strategies for the treatment of advanced-stage Hodgkin's lymphoma. Diehl V; Engert A; Re D Hematol Oncol Clin North Am; 2007 Oct; 21(5):897-914. PubMed ID: 17908627 [TBL] [Abstract][Full Text] [Related]
32. Induction chemotherapy in Barrett cancer: influence on surgical risk and outcome. Siewert JR; Lordick F; Ott K; Stein HJ; Weber WA; Becker K; Peschel C; Fink U; Schwaiger M Ann Surg; 2007 Oct; 246(4):624-8; discussion 628-31. PubMed ID: 17893499 [TBL] [Abstract][Full Text] [Related]
33. Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients. Chen MF; Tseng CJ; Tseng CC; Yu CY; Wu CT; Chen WC Cancer J; 2008; 14(3):200-6. PubMed ID: 18536561 [TBL] [Abstract][Full Text] [Related]
34. Radiotherapy for early-stage Hodgkin's lymphoma: a 21st century perspective and review of multiple randomized clinical trials. Bar Ad V; Paltiel O; Glatstein E Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1472-9. PubMed ID: 19028275 [TBL] [Abstract][Full Text] [Related]
35. The multidisciplinary management of rectal cancer. Meredith KL; Hoffe SE; Shibata D Surg Clin North Am; 2009 Feb; 89(1):177-215, ix-x. PubMed ID: 19186236 [TBL] [Abstract][Full Text] [Related]
36. Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity. Alektiar KM; Brennan MF; Healey JH; Singer S J Clin Oncol; 2008 Jul; 26(20):3440-4. PubMed ID: 18612160 [TBL] [Abstract][Full Text] [Related]
37. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. De Bruin ML; Dorresteijn LD; van't Veer MB; Krol AD; van der Pal HJ; Kappelle AC; Boogerd W; Aleman BM; van Leeuwen FE J Natl Cancer Inst; 2009 Jul; 101(13):928-37. PubMed ID: 19535773 [TBL] [Abstract][Full Text] [Related]
38. Technical and dosimetric considerations in multi-isocenter intensity modulated radiotherapy for nasopharyngeal carcinoma with small multileaf collimator. Xiance J; Shixiu W; Jianyi Y; Jinling Y Med Dosim; 2009; 34(1):9-15. PubMed ID: 19181249 [TBL] [Abstract][Full Text] [Related]
39. Low-dose involved-field radiotherapy as alternative treatment of nodular lymphocyte predominance Hodgkin's lymphoma. Haas RL; Girinsky T; Aleman BM; Henry-Amar M; de Boer JP; de Jong D Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1199-202. PubMed ID: 19131186 [TBL] [Abstract][Full Text] [Related]
40. Radiation therapy can still be used safely in combined modality approaches in patients with Hodgkin's lymphoma. Dabaja B; Cox JD; Buchholz TA J Clin Oncol; 2007 Jan; 25(1):3-5. PubMed ID: 17194900 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]